Articles de revues : « Biochemical markers »

1

Ahmed, Mohamed H. « Biochemical Markers ». American Journal of Clinical Pathology 127, n^o 1 (janvier 2007) : 20–22. http://dx.doi.org/10.1309/jxwum661t8vt1etx.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

Rothstein, Jeffrey. « Biochemical markers : Pro ». Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (septembre 2002) : S81. http://dx.doi.org/10.1080/146608202320374381.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

Mitsumoto, Hiroshi. « Biochemical markers : Con ». Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (septembre 2002) : S83. http://dx.doi.org/10.1080/146608202320374390.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Strong, Michael J. « Biochemical markers : Summary ». Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (septembre 2002) : S85—S90. http://dx.doi.org/10.1080/146608202320374408.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Sandberg, Dr K. « 3. Biochemical markers ». Animal Genetics 20, n^o 1 (24 avril 2009) : 56–83. http://dx.doi.org/10.1111/j.1365-2052.1989.tb01910.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Seishima, Mitsuru, Makiko Suzuki et Satoshi Maeda. « Atherosclerosis and biochemical markers. » SEIBUTSU BUTSURI KAGAKU 48, n^o 4 (2004) : 143–46. http://dx.doi.org/10.2198/sbk.48.143.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Selroos, Olof B. N. « Biochemical Markers in Sarcoidosis ». CRC Critical Reviews in Clinical Laboratory Sciences 24, n^o 3 (janvier 1986) : 185–216. http://dx.doi.org/10.3109/10408368609110273.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Đerić, Mirjana, Sunčica Kojić-Damjanov, Velibor Čabarkapa et Nevena Eremić. « Biochemical Markers of Atherosclerosis ». Journal of Medical Biochemistry 27, n^o 2 (1 janvier 2008) : 148–53. http://dx.doi.org/10.2478/v10011-008-0008-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Résumé :

Biochemical Markers of AtherosclerosisThis paper is a brief review of some lipid parameters and serum markers of inflammation in a view of their predictive relevance for the atherosclerotic disease. A discourse on the importance of measuring different lipids and lipoproteins, concentration of LDL particles and apolipoprotein levels is still underway. Also, the recommendations for apolipoprotein (a), phenotypization and other lipid markers have not yet been established. In recent years the recommendations imply simultaneous measuring of multiple markers and calculating the lipid index values such as lipid tetrad index (LTI), lipid pentad index (LPI) and atherogenic index of plasma (AIP). Several circulating markers of inflammation such as C-reactive protein, serum fibrinogen and elevated leukocyte number, are consistently associated with atherosclerosis. In spite of a lack of evidence on measuring the C-reactive protein in a wide population, the guidelines for its application in diagnostics and therapy of coronary heart disease were developed. Some proinflammatory cytokines, adhesion molecules and markers of leukocyte activation are promising markers, requiring, however, more detailed prospective evaluation. The question to be elucidated is if these inflammatory markers are directly involved in the pathogenic process.

9

Kanis, John. « Biochemical markers in osteoporosis ». Scandinavian Journal of Clinical and Laboratory Investigation 57 (1997) : 6–11. http://dx.doi.org/10.3109/00365519709168303.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

Ratcliffe, Anthony, et Markus J. Seibel. « Biochemical markers of osteoarthritis ». Current Opinion in Rheumatology 2, n^o 5 (octobre 1990) : 770–76. http://dx.doi.org/10.1097/00002281-199002050-00014.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

11

Kanis, John A. « Biochemical markers in osteoporosis ». Scandinavian Journal of Clinical and Laboratory Investigation 57, sup227 (janvier 1997) : 6–11. http://dx.doi.org/10.1080/00365519709168303.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

12

Jung, Rex E., Ronald A. Yeo, Stephen J. Chiulli, Wilmer L. Sibbitt, David C. Weers, Blaine L. Hart et William M. Brooks. « Biochemical markers of cognition ». NeuroReport 10, n^o 16 (novembre 1999) : 3327–31. http://dx.doi.org/10.1097/00001756-199911080-00014.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

13

Ikizler, T. Alp. « Biochemical markers : Clinical aspects ». Journal of Renal Nutrition 7, n^o 2 (avril 1997) : 61–64. http://dx.doi.org/10.1016/s1051-2276(97)90039-x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

14

Paselk, R. « Biochemical Markers for Cancer ». Biochemical Education 13, n^o 1 (janvier 1985) : 43. http://dx.doi.org/10.1016/0307-4412(85)90154-2.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

15

Stadtman, E. R. « Biochemical markers of aging ». Experimental Gerontology 23, n^o 4-5 (janvier 1988) : 327–47. http://dx.doi.org/10.1016/0531-5565(88)90036-8.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

16

Samoilova, I. G., M. V. Matveeva et D. E. Galyukova. « Biochemical markers of autism ». Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 124, n^o 1 (2024) : 55. http://dx.doi.org/10.17116/jnevro202412401155.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

17

Duffy, M. J. « Biochemical markers as prognostic indices in breast cancer ». Clinical Chemistry 36, n^o 2 (1 février 1990) : 188–91. http://dx.doi.org/10.1093/clinchem/36.2.188.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Résumé :

Abstract Traditional prognostic markers in breast cancer include histological variables such as tumor size, grade, and axillary node status. In recent years some new potential prognostic markers of a biochemical nature have been described: estradiol receptors, progesterone receptors, epidermal growth factor receptors, erbB-2 proto-oncogene, and certain proteolytic enzymes. None of these new markers excels axillary node status as a prognostic marker. Biochemical markers can, however, be evaluated with use of minimal surgery and may help distinguish the minority of aggressive axillary-node-negative breast cancers.

18

Watts, Nelson B. « Clinical Utility of Biochemical Markers of Bone Remodeling ». Clinical Chemistry 45, n^o 8 (1 août 1999) : 1359–68. http://dx.doi.org/10.1093/clinchem/45.8.1359.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Résumé :

Abstract Remodeling is essential for bone health. It begins with resorption of old bone by osteoclasts, followed by the formation of new bone by osteoblasts. Remodeling is coupled (formation is linked to resorption). After middle age or perhaps beginning earlier, bone loss occurs because resorption exceeds formation. This imbalance is accentuated by estrogen deficiency as well as by many diseases and conditions. Biochemical markers that reflect remodeling and can be measured in blood or urine include resorption markers (e.g., collagen cross-links) and formation markers (e.g., alkaline phosphatase). Bone markers exhibit substantial short-term and long-term fluctuations related to time of day, phase of the menstrual cycle, and season of the year, as well as diet, exercise, and anything else that alters bone remodeling. These biological factors, in addition to assay imprecision, produce significant intra- and interindividual variability in markers. Bone marker measurements are noninvasive, inexpensive, and can be repeated often. Unfortunately, most of the studies that provided insight on clinical situations did not focus on markers as a primary endpoint. Bone markers have been useful in clinical practice and have been helpful in understanding the pathogenesis of osteoporosis and the mechanism of action of therapies. In clinical trials, markers aid in selecting optimal dose and in understanding the time course of onset and resolution of treatment effect. Clinical questions that might be answered by bone markers include diagnosing osteoporosis, identifying “fast bone losers” and patients at high risk of fracture, selecting the best treatment for osteoporosis, and providing an early indication of the response to treatment. Additional information is needed to define specific situations and cut points to allow marker results to be used with confidence in making decisions about individual patients.

19

Zaitseva, O. V. « Biochemical markers of bone collagen type I metabolism ». Ukrainian Biochemical Journal 87, n^o 1 (27 février 2015) : 21–32. http://dx.doi.org/10.15407/ubj87.01.021.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

20

Franco, Leonardo, et Mario Alejandro Ortíz Salazar. « Biochemical markers of bone metabolism ». Revista Estomatología 18, n^o 1 (28 septembre 2017) : 30–34. http://dx.doi.org/10.25100/re.v18i1.5707.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Résumé :

The quantity and quality of bone tissue renewal are dependent on the generation of new bone (deposition) mediated by osteoblasts and the loss (resorption) mediated by osteoclasts. For each of these processes there are important markers that can be measured in serum or urine. Resorption markers are products of metabolic degradation of bone matrix in particu-lar of the type I collagen (hydroxyproline, pyridinoline and deoxypyridinoline). In addition, the resorptive activity can also be evaluated through the tartrate resistant acid phosphatase (TRAP) and calcium-creatinine ratio in urine. Bone formation markers are collagen proteins (ALP, OCN), non collagen (ONC, OPN, BSP) or fragments of collagen synthesis (procollagen peptides).

21

Rosen, Clifford J., et Alan Tenenhouse. « Biochemical markers of bone turnover ». Postgraduate Medicine 104, n^o 4 (octobre 1998) : 101–14. http://dx.doi.org/10.3810/pgm.1998.10.447.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

22

Accomando, Salvatore. « Biochemical markers in Celiac disease ». Frontiers in Bioscience S2, n^o 1 (2010) : 313–17. http://dx.doi.org/10.2741/s66.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

23

Bapayeva, G. B. « Biochemical markers of premature birth ». Journal of obstetrics and women's diseases 54, n^o 3 (1 novembre 2005) : 38–41. http://dx.doi.org/10.17816/jowd83449.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Résumé :

Summary: In this article the results of the research of diagnostic importance of myoglobin determination in peripheral blood and amniotic fluid, fetal fibronectin examination in cervicovaginal composition contents of a pregnant woman are represented in prediction of premature birth.

24

Koshul’ko, P. A., M. S. Kovalenko, Yu V. Abalenihina, A. I. Mirov, O. E. Golofast et E. D. Rokunov. « Biochemical markers of missed pregnancy ». Problemy reproduktsii 27, n^o 6 (2021) : 138. http://dx.doi.org/10.17116/repro202127061138.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

25

Lyubimova, N. V., et N. E. Kushlinskiy. « Biochemical markers of bone metastasis ». Advances in molecular oncology 2, n^o 1 (2 juin 2015) : 061. http://dx.doi.org/10.17650/2313-805x.2015.2.1.061-075.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

26

Lyubimova, N. V., et N. E. Kushlinskiy. « Biochemical markers of bone metastasis ». Advances in molecular oncology 2, n^o 1 (2 juin 2015) : 061. http://dx.doi.org/10.17650/2313-805x.2015.2.1.61-75.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

27

Kovářů, H., F. Kovářů, A. Fišerová, P. Zelníčková et E. Matalová. « Biochemical Markers of Lymphocyte Maturation ». Acta Veterinaria Brno 71, n^o 4 (2002) : 503–8. http://dx.doi.org/10.2754/avb200271040503.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

28

Delmas, Pierre D. « Biochemical markers of bone turnover ». Acta Orthopaedica Scandinavica 66, sup266 (janvier 1995) : 176–82. http://dx.doi.org/10.3109/17453679509157687.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

29

Griesmacher, A., P. Peichl, P. Pointinger, R. Mateau et H. Broll. « Biochemical markers in menopausal women ». Scandinavian Journal of Clinical and Laboratory Investigation 57 (1997) : 64–72. http://dx.doi.org/10.3109/00365519709168309.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

30

Apple, Fred. « Biochemical markers of thrombolytic success ». Scandinavian Journal of Clinical and Laboratory Investigation 59 (1999) : 60–66. http://dx.doi.org/10.3109/00365519909168328.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

31

Kemp, M., J. Donovan, H. Higham et J. Hooper. « Biochemical markers of myocardial injury ». British Journal of Anaesthesia 93, n^o 1 (juillet 2004) : 63–73. http://dx.doi.org/10.1093/bja/aeh148.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

32

Kerrigan, Richard W., et Ian K. Ross. « Extracellular Laccases : Biochemical Markers forAgaricusSystematics ». Mycologia 80, n^o 5 (septembre 1988) : 689–95. http://dx.doi.org/10.1080/00275514.1988.12025602.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

33

Lyubimova, N. V., T. K. Churikova, M. G. Toms et N. E. Kushlinskiy. « BIOCHEMICAL MARKERS OF NEUROENDOCRINAL TUMORS ». Tambov University Reports. Series : Natural and Technical Sciences 21, n^o 2 (2016) : 494–510. http://dx.doi.org/10.20310/1810-0198-2016-21-2-494-510.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

34

Krstic, Danijela, Nenad Tomic, Branimir Radosavljevic, Natasa Avramovic, Vesna Dragutinovic, Sanja Radojevic Skodric et Mirjana Colovic. « Biochemical Markers of Renal Function ». Current Medicinal Chemistry 23, n^o 19 (19 juillet 2016) : 2018–40. http://dx.doi.org/10.2174/0929867323666160115130241.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

35

Demers, Laurence M., Luis Costa et Allan Lipton. « Biochemical Markers and Skeletal Metastases ». Clinical Orthopaedics and Related Research 415 (octobre 2003) : S138—S147. http://dx.doi.org/10.1097/01.blo0000092979.12414.54.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

36

Thompson, R. P. H. « Biochemical markers of liver disease ». Current Opinion in Gastroenterology 1, n^o 3 (mai 1985) : 377–89. http://dx.doi.org/10.1097/00001574-198505000-00002.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

37

Matull, W. R. « Biochemical markers of acute pancreatitis ». Journal of Clinical Pathology 59, n^o 4 (1 avril 2006) : 340–44. http://dx.doi.org/10.1136/jcp.2002.002923.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

38

Engler, H., B. Thürlimann et F. Riesen. « Biochemical Markers of Bone Remodelling ». Oncology Research and Treatment 19, n^o 2 (1996) : 126–31. http://dx.doi.org/10.1159/000218778.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

39

Griesmacher, A., P. Peichl, P. Pointinger, R. Mateau et H. Bröll. « Biochemical markers in menopausal women ». Scandinavian Journal of Clinical and Laboratory Investigation 57, sup227 (janvier 1997) : 64–72. http://dx.doi.org/10.1080/00365519709168309.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

40

Apple, Fred S. « Biochemical markers of thrombolytic success ». Scandinavian Journal of Clinical and Laboratory Investigation 59, sup230 (janvier 1999) : 60–66. http://dx.doi.org/10.1080/00365519909168328.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

41

Gao, F., et D. N. F. Harris. « Biochemical markers of cerebral damage ». European Journal of Anaesthesiology 14, n^o 2 (mars 1997) : 113–17. http://dx.doi.org/10.1097/00003643-199703000-00001.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

42

De Jongh, R., C. De Deyne, G. Kenis, G. Vundelinckx, L. Merckx et R. Heylen. « Biochemical markers of brain ischaemia ». European Journal of Anaesthesiology 15, Supplement 17 (janvier 1998) : 14–15. http://dx.doi.org/10.1097/00003643-199801001-00011.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

43

Crofton, P. M., H. F. Stirling, E. Schönau, S. F. Ahmed, W. H. B. Wallace, J. C. Wade, R. Magowan et al. « Biochemical Markers of Bone Turnover ». Hormone Research 45, n^o 1 (1996) : 55–58. http://dx.doi.org/10.1159/000184832.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

44

Rambotti, Pietro. « Biochemical markers in lymphoproliferative diseases ». Critical Reviews in Oncology/Hematology 2, n^o 4 (janvier 1985) : 297–321. http://dx.doi.org/10.1016/s1040-8428(85)80006-8.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

45

Shepherd, J. « Biochemical risk markers of CHD ». Atherosclerosis 144 (mai 1999) : 144. http://dx.doi.org/10.1016/s0021-9150(99)80558-9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

46

Seibel, Markus J. « Biochemical markers of bone remodeling ». Endocrinology and Metabolism Clinics of North America 32, n^o 1 (mars 2003) : 83–113. http://dx.doi.org/10.1016/s0889-8529(02)00077-4.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

47

Garnero, Patrick, et Pierre D. Delmas. « BIOCHEMICAL MARKERS OF BONE TURNOVER ». Endocrinology and Metabolism Clinics of North America 27, n^o 2 (juin 1998) : 303–23. http://dx.doi.org/10.1016/s0889-8529(05)70007-4.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

48

Gavaghan, Mary. « Biochemical Markers in Myocardial Injury ». AORN Journal 70, n^o 5 (novembre 1999) : 839–54. http://dx.doi.org/10.1016/s0001-2092(06)61303-3.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

49

Yuasa, Isao, et Kazuo Umetsu. « Molecular aspects of biochemical markers ». Legal Medicine 7, n^o 4 (juillet 2005) : 251–54. http://dx.doi.org/10.1016/j.legalmed.2004.12.001.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

50

Gundberg, Caren M. « Biochemical Markers of Bone Formation ». Clinics in Laboratory Medicine 20, n^o 3 (septembre 2000) : 489–502. http://dx.doi.org/10.1016/s0272-2712(18)30049-0.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Articles de revues sur le sujet « Biochemical markers »

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres